Both in Biotechnology
Moderna vs Gilead Sciences
Over the past year MRNA returned +987.9% and GILD returned +41.9%; their daily moves had a correlation of 0.25.
MRNA +987.9% GILD +41.9%Growth of $1, one year, split-adjusted
| Metric | MRNA | GILD |
|---|---|---|
| Price | $258.38 | $174.48 |
| Market cap | $103.15B | $216.41B |
| Today | +13.11% | +4.19% |
| 1 month | +37.8% | +21.0% |
| 6 months | +429.6% | +28.0% |
| Year to date | +776.2% | +42.2% |
| 1 year | +937.3% | +43.0% |
| Revenue growth (YoY) | +2.1% | +6.8% |
| Gross margin | 35.9% | 81.1% |
| Net margin | −539.3% | 29.3% |
| P/E (TTM) | — | — |
| Price / sales | 46.3× | 7.0× |
| Net cash | $4.54B | -$19.79B |
| Dividend yield | — | 1.88% |
| Volatility (60d) | 231.0% | 26.6% |
| Short % of float | 9.0% | 1.6% |
| Next earnings | Nov 6, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).